WASHINGTON (TNND) — Thousands of bottles of antidepressants have been recalled by the U.S. Food and Drug Administration due to a cancer-causing chemical.

The voluntary recall for 7,107 bottles of the generic form of Cymbalta, known as Duloxetine, was initiated on October 10 by Breckenridge Pharmaceutical Inc. The recall lot was number 220128 and expired in December 2024.

Duloxetine is used to treat depression and anxiety, but can also be used for pain caused by nerve damage associated with diabetes, according to the Mayo Clinic. The product description includes 500 count 20 mg bottles manufactured by Towa Pharmaceutical Europe.

The FDA noted that the drug had the presence of an impurity of the nitrosamine drug substance that “may increase the risk of cancer if people are exposed above acceptable levels and for long periods of time.”

Classified as a Class II recall, the FDA describes it as a “situation in which use of or exposure to an violative product may cause temporary or medically reversible adverse health effects or in which the likelihood of serious adverse health effects is remote is.”

The FDA has not provided guidance on what to do with the recalled drug, so patients should contact their healthcare provider.